PMID: 8311533Dec 1, 1993

The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment

Annals of the Rheumatic Diseases
V Kyle, Brian Hazleman

Abstract

To examine the clinical course of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in a prospective study, after the initial two months. Seventy four patients with PMR/GCA were followed for a median of 60 weeks. Detailed clinical and laboratory records were made on each visit. Twenty per cent of patients with PMR developed GCA and 24% of patients with GCA developed PMR from the onset of symptoms. After two months, most patients experienced at least one relapse. Relapses and persistence of abnormal symptoms and signs were most common in patients with both PMR and GCA and least common in those with GCA alone. Relapses were most common in the first year and 54% occurred in association with steroid reduction. Major complications were rare. Laboratory parameters and temporal artery histology were not helpful in predicting relapse. Only 24% of patients were able to stop steroid treatment after two years. Clinicians should consider more frequent review in patients at times of steroid reduction and especially within the first six months of treatment.

References

Dec 20, 2002·The New England Journal of Medicine·Andrew J K Ostor, Brian Hazleman
Aug 9, 2008·Family Practice·Kevin BarracloughWilliam Hamilton
Feb 19, 2008·Current Opinion in Rheumatology·Nicolò Pipitone, Carlo Salvarani
Nov 26, 2010·Annals of the Rheumatic Diseases·Christian DejacoInternational Work Group for PMR and GCA
Apr 9, 2008·BMJ : British Medical Journal·Clement J Michet, Eric L Matteson
Jan 31, 2006·Journal of Clinical Pathology·W S SmellieC A Bloxham
Sep 19, 2003·Postgraduate Medical Journal·J M Calvo-Romero
Oct 17, 2006·Musculoskeletal Care·Sheena L Hennell
Jun 3, 2015·Rheumatology International·Michael SchirmerEric L Matteson
Sep 6, 2005·Survey of Ophthalmology·Waheeda Rahman, Farooq Z Rahman
Apr 29, 2005·Best Practice & Research. Clinical Rheumatology·Nicolò PipitoneCarlo Salvarani
Apr 13, 2013·European Journal of Internal Medicine·Nicolò Pipitone, Carlo Salvarani
Sep 10, 2014·Scottish Medical Journal·Patrick J RooneyPeter Balint
Sep 10, 2014·Scottish Medical Journal·Patrick J RooneyPeter Balint
Oct 10, 2001·Springer Seminars in Immunopathology·C A Stegeman, C G Kallenberg
May 27, 2020·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·María L de la TorreCecilia N Pisoni
Aug 22, 2019·Rheumatology Advances in Practice·Chetan MukhtyarColin Jones
Dec 14, 2011·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Marco A AlbaLuis Felipe Flores-Suárez
Nov 24, 1999·Scandinavian Journal of Rheumatology·J T Gran
Apr 7, 2010·Expert Opinion on Pharmacotherapy·Miguel A Gonzalez-GayRicardo Blanco
Jul 23, 2020·Rheumatology International·Christoffer MørkKresten K Keller

Citations

Feb 1, 1978·Annals of Internal Medicine·K A HustonL R Elveback
Oct 15, 1977·British Medical Journal·Brian HazlemanD Voak
Nov 1, 1976·Rheumatology and Rehabilitation·E N CoomesA G Kay
Nov 1, 1975·Rheumatology and Rehabilitation·A B Myles
Dec 1, 1972·Annals of Internal Medicine·P FauchaldB Oystese
Jan 1, 1971·Acta Rheumatologica Scandinavica·S Paulsen, T O Iversen
Aug 1, 1983·Annals of the Rheumatic Diseases·A R BehnA B Myles
Nov 1, 1982·Annals of Internal Medicine·T Y ChuangL T Kurland
Jul 1, 1980·American Heart Journal·K A Huston, Gene G Hunder
Jan 1, 1982·Scandinavian Journal of Rheumatology·L KnudsenL Krohn
Feb 1, 1981·Annals of the Rheumatic Diseases·J G Jones, Brian Hazleman
Oct 6, 1956·Lancet·L BAGRATUNI
Feb 23, 1963·British Medical Journal·L BAGRATUNI
Sep 1, 1963·The British Journal of Ophthalmology·A G WHITFIELDW T COOKE

Related Concepts

Histology Procedure
Predonine
Polymyalgia Rheumatica
Histology
Rhizomelic Pseudopolyarthritis
Juvenile Temporal Arteritis
Signs and Symptoms
Steroids
Giant Cell Arteritis
Relapse

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.